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Abstract

Objective: Infant cry characteristics reflect the neurological and medical status of the infant. This study compared the acoustic cry characteristics of infants born to mothers maintained on methadone during pregnancy with infants not exposed to methadone during pregnancy.
Methods: At 42 weeks post menstrual age, 89 crying episodes ranging in duration from 1.15 to 1.97 seconds were collected from 10 methadone exposed and 10 non-methadone exposed infants. Cry utterances were analysed acoustically using spectrographic displays and measures of cry utterance duration and fine-grained analyses of the fundamental frequency calculated for each cry.
Results: No between group differences were found on measures of cry duration or fundamental frequency. However, analyses of frequency perturbation showed that the cry utterances of methadone exposed infants were characterised by significantly higher levels of frequency perturbation than the cries of infants not exposed to methadone. These effects largely persisted after statistical control for the confounding effects of other maternal drug use during pregnancy.
Conclusions: The crying behaviour of infants exposed prenatally to the synthetic opiate, methadone, is characterised by higher levels of vocal fold vibratory perturbation than non-methadone exposed infants. These findings suggest the possibility of early, subtle neurological vulnerability in this high risk group of infants.
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Acoustic Cry Characteristics of Infants Exposed to Methadone during Pregnancy

	There is growing evidence to suggest that drug exposure during pregnancy is associated with elevated neurodevelopmental risks for the infant. These risks include higher rates of prematurity, birth complications, reduced head circumference, and disruptions to neurotransmitter systems, all of which may increase a child’s susceptibility to later cognitive and behavioural problems (1, 2). Furthermore, evidence suggests that these complications can manifest subtly and become cumulative over time (3). One drug for which neurodevelopmental follow-up information is limited, especially with respect to sophisticated and fine grained outcome measures, is methadone.
	Since the 1960s, methadone has been widely used in the treatment of individuals addicted to opiate drugs such as heroin, morphine and codeine (4). Methadone maintenance has also become the treatment of choice for pregnant women with an opiate addiction, despite their exclusion from earlier randomised controlled trials (5-8). Although findings remain mixed regarding the effects of prenatal methadone exposure on foetal and infant development, increasing evidence suggests that methadone exposed infants are at elevated risk of neonatal withdrawal, smaller head circumference, irritability, state dysregulation and poorer quality of movements (9-11). Animal studies also suggest disruptions to neurotransmitter systems and impaired brain growth (12-14). More recently, a volumetric MRI study of 11 year old children exposed to opiates and other drugs during pregnancy demonstrated reductions in cerebral volumes within the cerebral cortex, hippocampus, amygdala, accumbens, putamen, pallidum and cerebellar white matter (15).
        An important marker of neonatal neurological integrity that has been examined across a variety of infant groups is crying behaviour. Because cry represents a combination of respiratory, laryngeal and vocal tract functions, any unusual or deviant cry patterns are likely to reflect poor organisation in either parasympathetic or sympathetic strands of the nervous system (16). The most common acoustic features examined in infant crying that correspond to respiratory, laryngeal and vocal tract functions are cry duration, fundamental frequency (F0) and formant frequencies. See Barr (17) and Soltis (18) for a comprehensive overview of infant cry research..





       Study infants consisted of a sub-sample of ten (4 female, 6 male) ME and ten (4 female, 6 male) NE infants from a larger case-control study of the neurological effects of prenatal methadone exposure. All infants were term born singletons delivered at Christchurch Women’s Hospital, Christchurch New Zealand between 2004 and 2005. Pregnant women maintained on methadone were recruited in their third pregnancy trimester during antenatal visits that were a mandatory part of their treatment with the Christchurch Alcohol and Drug Service (recruitment rate: 90%).  Non-methadone treated comparison women were randomly identified from hospital delivery bookings over the same period (recruitment rate: 60%). Exclusion criteria for the larger study included: fetal alcohol syndrome; congenital abnormalities; HIV; gestational age <32 weeks or birth weight <1500grams. The overall mean methadone dose level prescribed for women in the methadone group was 57.83+25.90 mg/kg. For each trimester, methadone dose levels were: trimester 1 = 52.65 + 35.02; trimester 2 = 59.30 + 24.77; trimester 3 = 61.55 + 25.83 mg/kg. Maternal pregnancy drug use and infant clinical characteristics are described in Table 1.

Measures
	Information about women’s daily methadone dose levels throughout pregnancy was collated from hospital and drug service records. Close to birth, mothers were extensively interviewed about their licit (nicotine, alcohol, prescription drugs) and illicit (cannabis, opiates, benzodiazepines, stimulants) drug use during pregnancy. Detailed information about each infant’s perinatal course was also collected from clinical notes, hospital databases and maternal interview. At 42 weeks post menstrual age, infants underwent a comprehensive neurobehavioural assessment using the Neonatal Network Neurobehavioural Scale (NNNS) (19). This examination was completed by an examiner who was unaware of infant group status. Audiotaped cry samples were collected as part of this assessment. All study procedures and measures received ethical approval by our regional committee. Written informed consent was obtained from all parents or guardians.  

Cry Recording and Acoustic Analysis
        Cry samples were collected from each infant during Section C (Unwrap & Supine) of the NNNS administration procedure which involved the application of a tactile stimulation to the heel to the infant’s foot. This stimulation served as the method of cry elicitation. A similar method of cry sampling was employed by Nugent et al. (20). One complete crying episode (i.e., bout) was obtained from each infant in a supine position. All infants were in a quiet, restful state prior to cry recording and no attempts were made to elicit cries at particular phases of the infant’s respiratory breath cycle. A crying episode was defined as the total period of continuous crying activity (21). An episode of crying commenced with the first audible cry following tactile stimulation. A lapel microphone (Sony ECM-T145) was positioned approximately 15cm from the infant’s mouth. The microphone was attached to a digital minidisk recorder (Sony M2 N710). 
       On the basis of each infant’s episode of crying, a series of cry utterances were identified. Lester et al. (22) defined a cry utterance as an individual segment of crying that occurs during the expiratory phase of respiration. A cry utterance typically lasted for a period of 500 msec or longer. A total of five cry utterances were considered in the acoustic analysis for each infant. In some cases less than five cry utterances were produced by an infant. Forty-five cry utterances meeting criteria were collected from the ME infants and 44 from the NE infants. Prior to acoustic analysis, the digital recording of each infant’s crying episode was converted to a “wav” file using commercially available software (Acoustica 3.2). Each wav file was then imported to a signal processing system (PRAAT 4.3.12). Cry utterances were then measured using a combination of amplitude-by-time displays and narrow band spectrographic displays.  On the basis of these simultaneous displays, five acoustic measurements were obtained.
Cry Duration: Defined as the total time elapsed between the onset and offset of each cry utterance. Cry duration (msec) was measured by superimposing a pair of vertical cursors at the onset and offset of visible acoustic energy of each cry utterance. The average cry duration and corresponding standard deviation was calculated for each group.
Cry F0:  Defined as the lowest frequency component (in Hz) of the cry utterance. Measurements of F0 were made manually at 100 msec increments across the duration of each cry utterance and the average F0 and corresponding standard deviation computed for each group.
F0 Variability: Defined according to (a) the F0 coefficient of variation, and (b) F0 fluctuation. The coefficient of variation, calculated as the ratio of the F0 SD divided by the mean F0, has been shown to be a useful approach for comparing the variability of differing data sets (23). F0 fluctuation was determined on the basis of the individual F0 values collected at 100 msec intervals across each cry utterance.  Previous infant cry research has found F0 fluctuation to be a sensitive measure of the subtle variations in vocal fold vibration (24). Two measures of F0 fluctuations were calculated: 1) the percentage of F0 directionality and 2) F0 fluctuation factor. F0 directionality is a measure that reflects the number of times F0 changes direction across a cry utterance (i.e., when the algebraic sign changes direction) (25). F0 fluctuation factor was defined as the mean difference between the frequencies of adjacent F0 values divided by the mean frequency, multiplied by 100 (25). The F0 fluctuation factor formula adapted from Baken (1987) is given below. Fi refer to the individual F0 values and n refers to the number of F0 values sampled across each cry utterance. 
               

Statistical Analysis





	As shown in Table 2, the average crying durations for the ME and NE groups were 1.37 and 1.47 seconds, respectively. This between group difference was not statistically significant (p >.05).

Cry F0
      The average cry F0 of the ME and NE groups are shown in Table 2. The F0 of cries produced by the ME group was 504 Hz compared to 500 Hz for the NE group. This difference was not statistically significant (p >.05). 

F0 Variability
      The F0 coefficient of variation values calculated for the ME and NE groups are listed in Table 2. The ME group (M = 0.19) showed a clear tendency to higher F0 variability than the NE group (M = 0.13) (p =.05). Results of the F0 fluctuation analyses are also listed in Table 2. The average F0 fluctuation factor for the ME group (M = 112.9) was significantly larger compared to the NE group (M = 76.5) (p <.05). A similar result was found for the percentage of F0 directionality, with the F0 directionality for the ME group (M = 31) being significantly larger than the NE group (M = 24) (p <.05). An example of the differences in F0 variability demonstrated by NE and ME infants is illustrated in Figures 1 and 2.

Adjustment for the Effects of Other Maternal Drug Use





        The first hypothesis posed in the present study was that the cry durations of ME infants would be significantly different from NE infants. Past research, as well as the findings of this analysis, reveal poorer quality of movement amongst ME compared to NE infants (9, 10). It was anticipated that this impaired motor control might also be reflected in the durational pattern of crying behaviour. However, no such difference was found. Several explanations might account for this finding. First, it is possible that any differences in cry duration that may exist between ME and NE groups may have been too subtle to be detected in this analysis due to limited statistical power. Whilst the sample size used in this study was comparable with other cry studies showing differences between other high risk infant groups (17, 26), a larger sample would clearly have been desirable. Alternatively, it is possible that the poor movement patterns displayed by ME infants are not captured by acoustic measures of cry duration. Past research has used measures of cry duration to infer an infant’s respiratory effort and control of phonation (27). Although there is evidence to suggest that ME infants show normal respiratory activity during quiet breathing (28), respiratory activity during crying behaviour has not been assessed. It has been suggested that the sequential timing of muscle activity innervating both the laryngeal and respiratory systems are highly consistent (29). Specifically, electromyographic results indicate that the posterior cricoarytenoid (PCA, a vocal fold abductor) "activates" prior to diaphragmatic and intercostal muscles during quiet breathing. The early activation of the PCA serves to stiffen the upper airway during moments of inspiration and expiration, thereby helping to avoid airway obstruction (21). It is conceivable that this basic sequence of muscular timing is also evident during moments of phonation. In the case of ME and NE infants, both of whom seem to show normal quiet respiratory activity, the basic sequence of muscular timing related to the onset and offset of cry utterances appears to be similar. 
      The second hypothesis posed in this study was that the cries of ME infants would be characterised by a higher F0 compared to NE infants. This hypothesis was motivated by past reports indicating that ME infants tend to be physically smaller at birth than NE infants (9). It was predicted that this size difference might also be reflected in vocal tract anatomy, resulting in a higher cry pitch in ME infants. Based on comparison of various anthropometric features of study infants, there was a tendency, in this small sample, for ME infants to be symmetrically smaller than NE infants, however, these did not reach statistical significance. Similarly, the F0 of cries produced by ME infants did not differ significantly from the NE infants, although the cries of ME infants were generally higher in F0 (approximately 14 Hz). These findings suggest that between group differences in the average F0 of crying behaviour may be too subtle to offer useful insights into the neurological differences that may separate ME and NE infants.
     Whilst measurements of cry duration and average F0 failed to differentiate ME and NE infants, the various measures of F0 variability revealed fairly clear between group differences in crying behaviour. The third hypothesis was developed on the basis of past research noting that ME infants demonstrate poor self-regulation as well as high levels of irritability (9, 11). Assuming features of self-regulation also apply to the production of cry, one would expect higher acoustic variability in ME infants compared to NE infants. This was indeed the case for each measure of F0 variability, including the coefficient of variation, fluctuation factor and directionality. Furthermore, these between group differences in mean F0 variability persisted after covariate control for the correlated effects of maternal other drug use during pregnancy.
       Grauel et al. (24) demonstrated that measures of F0 variability can be useful for the prediction of developmental outcome. Interestingly, aside from Grauel (24), there has been limited attention to F0 fluctuation in infant crying. It is important to recognise that measures of average F0 reflect the longer term pattern of vocal fold vibration. That is, the laryngeal activity that encompasses a range of changes in F0 across a moment of phonatory behaviour, such as a cry utterance. It is the average F0 that reflects the basic pitch of infant crying, and also serves to differentiate linguistic intent in speech production. On the other hand, measures of F0 variability reflect “short-term” (cycle-to-cycle) variations in vocal fold vibration. That is, the fluctuations in laryngeal activity that occur within a single moment of phonatory behaviour. These short term F0 variations are thought to be a direct consequence of laryngeal adjustments and reflect automatic (albeit subtle) processes of vocal fold vibration (30).
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Table 1.  Maternal Drug Use during Pregnancy and Infant Clinical Characteristics at Birth of Methadone Exposed and Non-methadone Exposed Infants.
 
Measure	Methadone Exposed Infants (N=10)	Non-methadone Exposed Infants (N=10)	2 / t                          	p







Mean (SD) number other drugs used in pregnancy	1.70 (1.06)	0.60 (0.84)	2.57	.02
Infant Clinical Characteristics			
Mean (SD) gestation (wks)	39.08 (0.90)	39.09 (1.17)	-0.21	NS
Mean (SD) birth weight (g)	3238.00 (472.98)	3438.00 (442.77)	 -0.98	NS
Mean (SD) length (cm)	51.60 (3.31)	52.20 (3.23)	 -0.41	.NS
Mean (SD) head circumference (cm)	34.80 (1.77)	34.65 (1.25)	0.22	NS
Mean (SD) days hospital	17.40 (12.41)	2.90 (1.60)	3.66	.005
Mean (SD) highest Finnegan score	13.20 (2.57)	0.20 (0.63)	15.51	<.0001
Mean (SD) NNNS stress abstinence score	0.17 (0.09)	0.10 (0.04)	2.28	.04
Mean (SD) NNNS quality of movement score	3.82 (0.15)	4.67 (0.80)	-1.88	.08
% Neonatal Abstinence Syndrome *	80.0	0.0	13.33	<.0001
*  An infant was diagnosed with Neonatal Abstinence Syndrome if they obtained three consecutive Finnegan scores > 8.


Table 2. Mean (SD) Acoustic Cry Characteristics of Methadone Exposed and Non-methadone Exposed Infants.

Cry Measure	Methadone Exposed Infants (N=10)	Non-methadone Exposed Infants (N=10)	p
Utterance duration (secs)	1.37 (0.25)	1.47 (0.22)	NS
F0 (Hz)	504.16 (145.70)	500.12 (256.81)	NS
F0 coefficient of variation (Hz)	0.19 (0.09)	0.13 (0.05)	.05
F0 fluctuation (Hz)	112.93 (59.40)	76.51 (26.53)	.04
F0 percentage directional change	30.77 (8.64)	23.57 (9.49)	.03


Table 3. Differences in Acoustic Cry Characteristics between Methadone Exposed and Non-methadone Exposed Infants, a) Before Adjustment and b) After Adjustment for the Effects of Other Maternal Licit and Illicit Drug Exposure.

Cry Measure	a) Mean Difference (SE)	p	b) Mean Difference (SE)	p
F0 coefficient of variation (Hz)	-0.06 (0.03)	.05	-0.06 (0.04)	.07
F0 fluctuation (Hz)	-36.42 (20.76)	.04	-32.67 (24.12)	.08








Figure 1. Illustrative cry examples from a non-methadone exposed infant (A) and a methadone-exposed infant (B). The upper panel for each shows the amplitude-by-time display of the cry whereas the lower panel is a spectrographic (frequency-by-time) display of the same cry. The cry pattern in A is one of a stable fundamental frequency (F0) and the one shown in B depicts a highly unstable fundamental frequency (F0).
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